Abeona Therapeutics(ABEO)
CLEVELAND, OHBiotechnology
Focus: Abeona Therapeutics is a Cleveland-based public biotech focused on gene transfer therapies for rare genetic diseases, particularly Sanfilippo syndrome and epidermolysis bullosa, operating at mid-cap scale with 1,001–5,000 employees.
Profile data last refreshed 3h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
1001-5000
Open Jobs
2
Should You Work at Abeona Therapeutics?
AI assessmentHigh-risk, high-reward opportunity best suited for scientists and clinical professionals willing to accept restructuring or acquisition risk in exchange for early exposure to transformative rare-disease therapies.
Why Work Here
- Pursuing multiple Phase 3 candidates (EB-101, MSI-78) with near-term regulatory catalysts in high-unmet-need rare diseases.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$6M
Pipeline & Clinical Trials
ABO-101
Mucopolysaccharidosis III-BClinical Trials (1)
NCT04655911A Long-term Follow-up Study of Patients With MPS IIIB Treated With ABO-101
N/AHelp build intelligence for Abeona Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.